Press release
The Research Antibodies & Reagents Market Size Is Projected To Reach USD 16.1 Billion By 2027, At A CAGR Of 6.7% | Growing Demand For High-Quality Antibodies For Research Reproducibility, and Increasing R&D Activity
Research Antibodies Market
The research antibodies & reagents market size is projected to reach USD 16.1 billion by 2027, at a CAGR of 6.7% during the forecast period. Factors such as the growth in proteomics and genomics research, growing demand for high-quality antibodies for research reproducibility, and increasing R&D activity in the life sciences industry will drive the market.
The research antibodies and reagents market consists of sales of buffers, fixatives, solvents, and enzymes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Get PDF Sample Report + All Related Table and Graphs @: https://www.reportspublisher.com/report/Research-Antibodies-and-Reagents-Market/request-sample
Key Companies & Market Share Insights
Key players in this market are implementing various strategic initiatives such as mergers and acquisitions, research collaborations, and geographical expansion to expand their market presence. For instance, in February 2022, Abcam and Twist Bioscience Corporation entered into a licensing deal to use the Twist VHH phage library for antibody development, discovery, and commercialization for diagnostic and research applications. Some prominent players in the global research antibodies market include:
• Abcam Plc.
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Cell Signalling Technology, Inc.
• Santa Cruz Biotechnology Inc.
• PerkinElmer, Inc.
• Becton, Dickinson and Company
• Bio-Techne Corporation
• Proteintech Group, Inc.
• Jackson ImmunoResearch Inc.
The need for research antibodies has greatly increased as a result of these intense R&D operations for the development of novel vaccination and therapy techniques. Additionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibody therapy study for COVID-19.
Interested in Purchasing this Report? Click here @ https://www.reportspublisher.com/checkout?report=RP-204562&type=single
The study categorizes the Research Antibodies and Reagents market based on product, technology, application, end User and regional and global level.
By Product
• Reagent
• Media & Sera
• Stains & Dyes
• Fixatives
• Buffers
• Solvents
• Enzymes
• Probes
• Other Reagents
• Antibodies
By Type
• Primary Antibodies
• Secondary Antibodies
By Form
• Monoclonal
• Polyclonal
• Recombinant
By Source
• Mice
• Rabbits
• Other Sources
By Research Area
• Oncology
• Infectious Diseases
• Immunology
• Neurobiology
• Stem Cells
• Other Research Areas
By Technology
• Western Blotting
• Flow Cytometry
• Enzyme-linked immunosorbent assay (ELISA)
• Immunohistochemistry
• Immunofluorescence
• Immunoprecipitation
• Other Technologies
By Application
• Proteomics
• Drug Development
• Genomics
By End User
• Covid-19 Impact, By End User
• Pharmaceutical & Biotechnologies Industries
• Academic & Research Institutions
• Contract Research Organizations
Get Customized report at https://www.reportspublisher.com/report/Research-Antibodies-and-Reagents-Market/request-customization
Recent Developments
• In 2022, Abcam plc announced a licensing agreement with twist bioscience, under which Abcam will use a proprietary Twist VHH phage library for antibody discovery, development and commercialization for diagnostic and research applications
• In 2021, Thermo fisher acquired PPD, expanding value proposition for biotech and pharmaceutical customers with the addition of PPD's leading clinical research services advances work in bringing life-changing therapies to market, benefitting patients around the world
• In 2020, Thermo Fisher Scientific (US) collaborated with Wuxi and Mayo Clinic To secure FDA authorization for testing COVID-19 with ELISA for detecting both IgM and IgG antibodies
• In 2020, Merck (Germany) partnered with Elypta (Sweden) to provide contract manufacturing services for Elypta's clinical diagnostic liquid biopsy kits
• In 2020, Abcam (UK) acquired Marker Gene Technologies (US) To extend Abcam's assay and labeling capabilities
Frequently Asked Questions (FAQ):
• What is the size of Research Antibodies Market?
• What are the major growth factors of Research Antibodies Market ?
• Who all are the prominent players of Research Antibodies Market ?
Explore ReportsPublisher's Coverage on the BioTechnology Domain
Stem Cell Assays Market Size, Share & Trends Analysis Report - https://www.reportspublisher.com/report/Stem-Cell-Assays-Market
Nucleic Acid Isolation & Purification Market Size, Share & Trends Analysis Report - https://www.reportspublisher.com/report/Nucleic-Acid-Isolation-and-Purification-Market
In Vitro Toxicology Testing Market Size, Share & Trends Analysis Report - https://www.reportspublisher.com/report/In-Vitro-Toxicology-Testing-Market
Cell Analysis Market Size, Share & Trends Analysis Report - https://www.reportspublisher.com/report/Cell-Analysis-Market
3D Cell Culture Market Size, Share & Trends Analysis Report - https://www.reportspublisher.com/report/3D-Cell-Culture-Market
Plasma Fractionation Market Size, Share & Trends Analysis Report - https://www.reportspublisher.com/report/Plasma-Fractionation-Market
Tangential Flow Filtration Market Size, Share & Trends Analysis Report - https://www.reportspublisher.com/report/Tangential-Flow-Filtration-Market
Human Microbiome Market Size, Share & Trends Analysis Report - https://www.reportspublisher.com/report/Human-Microbiome-Market
Metagenomic Sequencing Market Size, Share & Trends Analysis Report - https://www.reportspublisher.com/report/Metagenomic-Sequencing-Market
Exosome Research Market Size, Share & Trends Analysis Report - https://www.reportspublisher.com/report/Exosome-Research-Market
Alex
USA Office
1050 West Lakes Drive, West Covina,
California 91790, Los Angeles, United States
E-mail: help@reportspublisher.com
Phone: +1-323-982-8916
REPORTS PUBLISHER is a market research and consultative company that provides market research reports and business insights to large and small & medium enterprises. The company supports its clients to conceive business policies and accomplish sustainable growth in their particular market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Research Antibodies & Reagents Market Size Is Projected To Reach USD 16.1 Billion By 2027, At A CAGR Of 6.7% | Growing Demand For High-Quality Antibodies For Research Reproducibility, and Increasing R&D Activity here
News-ID: 2936192 • Views: …
More Releases from Reports Publishers
Skin Packaging Market by Material (Plastic films, Paper & Paperboard, Others), T …
The global skin packaging market is projected to reach USD 9.67 Billion in 2020, growing at a CAGR of 4.94% from 2015 and 2020. High disposable incomes and changing lifestyles have led to an increase in the consumption of packed goods, which in turn drive the demand for skin packaging. Moreover, with increasing awareness about environmental hazards, the market will adopt technologies to develop sustainable packaging, which is environment-friendly, cost-effective,…
Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platf …
The global next generation sequencing market in terms of revenue was estimated to be worth $13 billion in 2022 and is poised to reach $27 billion by 2027, growing at a CAGR of 15.7% from 2022 to 2027. The growth of the market is attributed to declining costs of genome sequencing, growing incidence of cancer, and launch of new NGS platforms.
The market is segmented into five major regions-North America, Europe,…
Global Optical Imaging Market Is Projected To Reach $3,865.7 Million By 2030 Reg …
The Optical Imaging Market is Segmented by Product (Imaging Systems, Illumination Systems, Lenses, and Software), Application (Ophthalmology, Dentistry, Dermatology, Cardiology, Neurology, Oncology, and Biotechnology and Research), End User (Diagnostic Imaging Centre, Hospitals, and Research Laboratories), and Geography.
Optical imaging systems offer great potential for diagnosis, improving disease prevention and treatment in the healthcare sector. Widening areas of application and increasing preference for noninvasive technology coupled with the rising prevalence of chronic…
Global Therapeutic Drug Monitoring Market Is Poised To Reach $2.9 Billion By 202 …
Therapeutic Drug Monitoring Market is Segmented by Technology (Immunoassays and Proteomic Technologies), Drug Class (Antiarrhythmic Drugs, Immunosuppressants, Antiepileptic Drugs, and Other Drug Classes), End-user (Hospitals, Diagnostic Centers, and Other End-users), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America).
The report offers the value (in USD million) for the above segments. The global therapeutic drug monitoring market in terms of revenue was estimated to be worth…
More Releases for Antibodies
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The arthritis monoclonal antibodies…
Global Multispecific Antibodies Market Size Antibodies Sales Forecast 2029
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights:
• Global & Regional Market Analysis
• Global Multispecific Antibodies Market Opportunity: > USD 40 Billion
• Global Multispecific Antibodies Market Sales In 2023: > USD 8 Billion
• Number Of Approved Multispecific Antibodies: 14
• Approved Antibodies Global, Regional, Annual & Quarterly Sales Insight
• Approved Antibodies Dosage & Pricing Insight
• Number Of Multispecific Antibodies: In Clinical Trials: > 900
• Comprehensive Insight On All Antibodies In Clinical Trials By…
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights:
• Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms
• Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023)
• Global Bispecific Antibodies Market Size 2023: > USD 8 Billion
• Global Bispecific Antibodies Market Forecast Till 2029
• Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023)
• Approved Bispecific Antibodies Regional Sales (2018 till 2023)
• Clinical and Commercial Insight On Approved…
Emergence of Tetravalent Antibodies
The emergence of tetravalent antibodies represents a significant advancement in the field of therapeutic antibodies, offering new possibilities for treating complex diseases such as cancer, infectious diseases, and autoimmune disorders. These innovative molecules, capable of binding to four antigens or epitopes simultaneously, provide enhanced specificity, efficacy, and versatility, addressing the limitations of traditional monoclonal and even bispecific antibodies.
Download Bispecific, Trispecific and Tetraspecific Antibodies Report:
https://www.kuickresearch.com/ccformF.php?t=1721642510
Tetravalent antibodies are designed to engage…
